Rubin Steven D

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

+122.6%

median move per position

+9.2%

S&P 500 median, same spans

1 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$19.4K bought

All filings on record

Every Form 4 transaction we track for this filer

All4Buys2Sells0

Stock	Transaction	Date	~6mo vs S&P
OPKOPKO HEALTH, INC.	Tax $65.0K · 53,266 sh	2026-07-24	—
ENTXEntera Bio Ltd.	Buy $7.5K · 5,000 sh	2026-02-12	—
ENTXEntera Bio Ltd.	Buy $12.0K · 10,000 sh	2026-02-09	—
RDVTRed Violet, Inc.	Grant — · 4,450 sh	2025-12-19	—

OPKTax

2026-07-24 · OPKO HEALTH, INC.

$65.0K

—

ENTXBuy

2026-02-12 · Entera Bio Ltd.

$7.5K

—

ENTXBuy

2026-02-09 · Entera Bio Ltd.

$12.0K

—

RDVTGrant

2025-12-19 · Red Violet, Inc.

4,450

—

4 filings·Every Form 4 on record, with outcomesPro →

Filing in the same companies

Other insiders active in these names in the last 3 years

LW

Livek William Paul

RDVT · last 2026-08-27

GG

Germano Geno J

ENTX · last 2026-08-07

LA

Logal Adam

OPK · last 2026-07-24

DJ

Dell Jeffrey Alan

RDVT · last 2026-06-01

DD

Dubner Derek

RDVT · last 2026-06-01

MD

MacLachlan Daniel

RDVT · last 2026-06-01

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.